NJ S1102

Mandates all New Jersey health insurers provide coverage for continuous glucose monitoring systems when prescribed for treatment of glycogen storage disease.

Applies to hospital service corporations, medical service corporations, health service corporations, individual and group health insurance policies, HMOs, and small employer health benefits plans.

Requires the State Health Benefits Commission and School Employees' Health Benefits Commission to include this coverage in contracts they purchase.

Coverage must be provided to the same extent as any other medical condition under the policy or contract.

Takes effect on the first day of the seventh month following enactment, applying to all health benefits plans delivered, issued, executed, or renewed after that date.